| Minimally invasive (n = 13) | Open (n = 12) | p value |
---|---|---|---|
Age (years) | 41.0 ± 13.5 | 35.3 ± 15.4 | 0.326 |
Gender (F:M) | 11:2 | 11:1 | 0.588 |
Symptomatic (yes/no) | 3/10 | 6/6 | 0.161 |
BMI (kg/m2) | 22.8 ± 2.6 | 21.9 ± 2.5 | 0.380 |
Tumor size (cm) | 2.6 ± 1.0 | 4.5 ± 1.8 | 0.004* |
Preoperative stage | Â | Â | 0.645 |
 Ia | 4 (30.8%) | 2 (16.7%) |  |
 Ib | 9 (69.2%) | 10 (83.3%) |  |
Operation | Â | Â | 0.411 |
 PPPD | 7 (53.8%) | 9 (75%) |  |
 CP | 6 (46.2%) | 3 (25%) |  |
OR time (min) | 417.2 ± 115.6 | 413.9 ± 132.4 | 0.949 |
Blood loss (mL) | 277.7 ± 250.8 | 664.2 ± 512.4 | 0.024* |
Need for transfusion (yes/no) | 0/13 | 4/8 | 0.023* |
Pancreas description (soft/hard) | 13/0 | 12/0 | Â |
Pancreatic duct size (mm) | 1.15 ± 0.83 | 1.43 ± 1.2 | 0.496 |
Resection type | All R0 | All R0 | Â |
Hospital length of stay (days) | 11.5 ± 5.3 | 27.4 ± 15.3 | 0.002* |
Complication incidence | 4 (30.8%) | 9 (75%) | 0.027* |
POPF (grade A/grade B) | 2 (15.4%)/2 (15.4%) | 3 (25%)/1 (8.33%) | 0.465 |